181 related articles for article (PubMed ID: 16785491)
21. Tyrosine kinase 2 plays critical roles in the pathogenic CD4 T cell responses for the development of experimental autoimmune encephalomyelitis.
Oyamada A; Ikebe H; Itsumi M; Saiwai H; Okada S; Shimoda K; Iwakura Y; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
J Immunol; 2009 Dec; 183(11):7539-46. PubMed ID: 19917699
[TBL] [Abstract][Full Text] [Related]
22. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice.
Oliver AR; Lyon GM; Ruddle NH
J Immunol; 2003 Jul; 171(1):462-8. PubMed ID: 12817031
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice.
Mendel I; Katz A; Kozak N; Ben-Nun A; Revel M
Eur J Immunol; 1998 May; 28(5):1727-37. PubMed ID: 9603480
[TBL] [Abstract][Full Text] [Related]
24. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein.
Lyons JA; Ramsbottom MJ; Cross AH
Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610
[TBL] [Abstract][Full Text] [Related]
25. Experimental autoimmune encephalomyelitis (EAE) in CCR2(-/-) mice: susceptibility in multiple strains.
Gaupp S; Pitt D; Kuziel WA; Cannella B; Raine CS
Am J Pathol; 2003 Jan; 162(1):139-50. PubMed ID: 12507897
[TBL] [Abstract][Full Text] [Related]
26. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H
J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634
[TBL] [Abstract][Full Text] [Related]
27. Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice.
Tan SL; Zhao J; Bi C; Chen XC; Hepburn DL; Wang J; Sedgwick JD; Chintalacharuvu SR; Na S
J Immunol; 2006 Mar; 176(5):2872-9. PubMed ID: 16493044
[TBL] [Abstract][Full Text] [Related]
28. Antibodies to myelin oligodendrocyte glycoprotein are not involved in the severity of chronic non-remitting experimental autoimmune encephalomyelitis.
Sekiguchi Y; Ichikawa M; Takamoto M; Ota H; Koh CS; Muramatsu M; Honjo T; Agematsu K
Immunol Lett; 2009 Feb; 122(2):145-9. PubMed ID: 18824198
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen.
Vollmer TL; Liu R; Price M; Rhodes S; La Cava A; Shi FD
J Immunol; 2005 Mar; 174(5):2696-701. PubMed ID: 15728477
[TBL] [Abstract][Full Text] [Related]
30. Induction of low dose oral tolerance in monocyte chemoattractant protein-1- and CCR2-deficient mice.
Gonnella PA; Kodali D; Weiner HL
J Immunol; 2003 Mar; 170(5):2316-22. PubMed ID: 12594253
[TBL] [Abstract][Full Text] [Related]
31. Regulation of experimental autoimmune encephalomyelitis in the C57BL/6J mouse by NK1.1+, DX5+, alpha beta+ T cells.
Fritz RB; Zhao ML
J Immunol; 2001 Mar; 166(6):4209-15. PubMed ID: 11238673
[TBL] [Abstract][Full Text] [Related]
32. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.
Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS
J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103
[TBL] [Abstract][Full Text] [Related]
33. IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis.
Klein RS; Izikson L; Means T; Gibson HD; Lin E; Sobel RA; Weiner HL; Luster AD
J Immunol; 2004 Jan; 172(1):550-9. PubMed ID: 14688366
[TBL] [Abstract][Full Text] [Related]
34. Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.
Liu L; Huang D; Matsui M; He TT; Hu T; Demartino J; Lu B; Gerard C; Ransohoff RM
J Immunol; 2006 Apr; 176(7):4399-409. PubMed ID: 16547278
[TBL] [Abstract][Full Text] [Related]
35. ERK1-deficient mice show normal T cell effector function and are highly susceptible to experimental autoimmune encephalomyelitis.
Nekrasova T; Shive C; Gao Y; Kawamura K; Guardia R; Landreth G; Forsthuber TG
J Immunol; 2005 Aug; 175(4):2374-80. PubMed ID: 16081808
[TBL] [Abstract][Full Text] [Related]
36. Deficiency of fatty acid-binding proteins in mice confers protection from development of experimental autoimmune encephalomyelitis.
Reynolds JM; Liu Q; Brittingham KC; Liu Y; Gruenthal M; Gorgun CZ; Hotamisligil GS; Stout RD; Suttles J
J Immunol; 2007 Jul; 179(1):313-21. PubMed ID: 17579051
[TBL] [Abstract][Full Text] [Related]
37. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis.
Fife BT; Huffnagle GB; Kuziel WA; Karpus WJ
J Exp Med; 2000 Sep; 192(6):899-905. PubMed ID: 10993920
[TBL] [Abstract][Full Text] [Related]
38. A nitric oxide releasing derivative of flurbiprofen inhibits experimental autoimmune encephalomyelitis.
Furlan R; Kurne A; Bergami A; Brambilla E; Maucci R; Gasparini L; Butti E; Comi G; Ongini E; Martino G
J Neuroimmunol; 2004 May; 150(1-2):10-9. PubMed ID: 15081244
[TBL] [Abstract][Full Text] [Related]
39. IFN-gamma shapes immune invasion of the central nervous system via regulation of chemokines.
Tran EH; Prince EN; Owens T
J Immunol; 2000 Mar; 164(5):2759-68. PubMed ID: 10679118
[TBL] [Abstract][Full Text] [Related]
40. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Weissert R; de Graaf KL; Storch MK; Barth S; Linington C; Lassmann H; Olsson T
J Immunol; 2001 Jun; 166(12):7588-99. PubMed ID: 11390515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
